Research News and Research

RSS

Missouri sets 72-hour wait for women seeking abortions

The Republican-controlled legislature overrode Democratic Gov. Jay Nixon's veto to enact one of the most stringent waiting periods in the nation that includes no exception for cases of rape or incest.

12 Sep 2014

New research analyzes transmission rates of Ebola in West African countries

New research from Arizona State University and the University of Tokyo that analyzes transmission rates of Ebola in West African countries shows how rapidly the disease is spreading.

12 Sep 2014

Human stem cells can be reset to their native undifferentiated state

Scientists at the Babraham Institute, in collaboration with colleagues at the Cambridge Stem Cell Institute and the European Bioinformatics Institute, have made a breakthrough in stem cell research. Their paper, published today in Cell, describes how human stem cells can be reverted back to non-specialised cells.

11 Sep 2014

PwC's HRI releases new report on retail health insurance

PwC's Health Research Institute today released a new report – The Rise of Retail Health Coverage – detailing how retail health insurance marketplaces, known as exchanges, are dramatically changing both the employer benefits environment and the health insurance business.

11 Sep 2014

ChromaDex signs NIAGEN supply agreement with Healthy Directions

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it has entered into an ingredient supply agreement with Healthy Directions, a direct-to-consumer nutritional supplement retailer and wholly-owned subsidiary of Helen of Troy Limited.

11 Sep 2014

Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Loyola University Health System will open an acupuncture clinic for men and women with pelvic health disorders this fall. The clinic will use acupuncture to treat patients with common conditions such as pelvic pain, nausea from pelvic surgery, interstitial cystitis, painful bladder syndrome, postoperative pain, prostatitis and overactive bladder.

11 Sep 2014

New collaborative approach could help improve diabetes care in China

Diabetes has become a major public health crisis in China, with an annual projected cost of 360 billion RMB (nearly 35 billion British pounds) by 2030, but a new collaborative approach to care that uses registries and community support could help improve diabetes care, according to a new three-part Series about diabetes in China published in The Lancet Diabetes & Endocrinology.

11 Sep 2014

NSF, NIH, USDA receive more than $12 million in new EEID grants

Ebola, MERS (Middle East Respiratory Syndrome), malaria, antibiotic-resistant infections: Is our interaction with the environment somehow responsible for their increased incidence?

11 Sep 2014

Measles infections worse than flu, new study reveals

Measles causes significant absence from school or work and has a much larger impact on people’s daily lives than illnesses like flu or chicken pox, according to a new study by researchers from the London School of Hygiene & Tropical Medicine and Public Health England.

11 Sep 2014

AstraZeneca is developing new PARP inhibitor for treatment of ovarian cancer

The ovarian cancer market is highly active with several promising candidates having reached the late stages of development. Three PARP inhibitors, Lynparza (AstraZeneca), niraparib (Tesaro) and rucaparib (Clovis Oncology), which induce cell death in mutated [BRCA-deficient] cancer cells, have been identified by Datamonitor Healthcare as front runners.

11 Sep 2014

University of Michigan Health System becomes one of best places for young doctors to train

Doctors nationwide rate the University of Michigan Health System as one of the best places for young doctors to train in their chosen field, across 20 medical specialties, according to a new ranking released today.

11 Sep 2014

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

11 Sep 2014

Research shows potential for misunderstanding between doctors and patients about critical health issue

African American women and their female children have the highest obesity prevalence of any demographic group and are more likely to underestimate their body weight than white women.

11 Sep 2014

Researchers discover new details of how autoantibodies destroy healthy cells in skin

University at Buffalo researchers and colleagues studying a rare, blistering disease have discovered new details of how autoantibodies destroy healthy cells in skin.

11 Sep 2014

ARC selects Elsevier’s Scopus as bibliometric provider for 2015 ERA assessment

Third time consecutive selection underscores Scopus' continuing relevance and value in supporting research excellence in Australia

11 Sep 2014

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.

11 Sep 2014

Olympus launches objective lenses, enabling super-deep imaging of tissues, live-cell imaging and light sheet microscopy techniques

Dedicated to multiphoton excitation microscopy, Olympus introduces its XLPLN10XSVMP and XLSLPLN25XGMP objective lenses with an 8 mm working distance and support for a large range of refractive indices (RI). The objectives enable super-deep imaging of tissues treated with the latest clearing agents as well as live-cell imaging and light sheet microscopy techniques.

From Evident Corporation - Life Sciences 11 Sep 2014